亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Anti-Progesterone in Breast Cancer Chemoprevention

技术应用
Treatment of BRCA1 mediated breast cancer
详细技术说明
Treatment with anti-progesterone, mifepristone, prevents tumorigenesis in mice carrying mutated Brca1/p53 alleles. Anti-progesterone pellet containing 30mg/60 days constant release mifepristone (RU486), or placebo pellet was implanted into twelve 3- and two 4- month-old mice. Mice were monitored weekly for tumor formation. All control mice or placebo pellet treated mice developed palpable tumors. In the RU486 treated group no palpable tumors were detected.The invention is published in Science 1 December 2006 314: 1467-1470
*Abstract

BRCA1 is a breast cancer susceptibility gene. According to estimates of lifetime risk, 36 to 85 percent of women with an altered BRCA1 or BRCA2 gene will develop breast cancer.

*IP Issue Date
Dec 13, 2016
*Principal Investigation

Name: Yoon Kim

Department:


Name: Eva Y H P Lee

Department:


Name: Ying Li

Department:


Name: Aleksandra Poole

Department:

申请号码
9517240
其他

Tech ID/UC Case

18780/2006-560-0


Related Cases

2006-560-0

国家/地区
美国

欲了解更多信息,请点击 这里
移动设备